Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis (Q35906614)
Jump to navigation
Jump to search
scientific article published on 10 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis |
scientific article published on 10 January 2011 |
Statements
1 reference
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis (English)
1 reference
Pierre I Karakiewicz
1 reference
Maxine Sun
1 reference
Shahrokh F Shariat
1 reference
Richard K Lee
1 reference
Thomas F Chromecki
1 reference
Mesut Remzi
1 reference
Caroline Savage
1 reference
Douglas S Scherr
1 reference
Michael J Marberger
1 reference
10 January 2011
1 reference
1 reference
2892-2897
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference